Biotech CFO Role – Philadelphia
Date:
August 10, 2020
Location:
Northwest Philadelphia
Company:
2 Drugs in phase 3, will be public and revenue generating in 90 days
2021 revenues conservatively estimated at $3 billion
On run rate to increase value by 1768% – company valuation has already increased $340 million over last 10 days w/o
COVID-19 fast track designation for drugs shown to reduce COVID-19 ventilator patient mortality rate from 80% to under 10%
Drugs target specific lung cells – no other proposed treatments target these cells
Suicidal Bipolar Depression – estimated market of $2.2 billion annually (per IQVIA ) patented with no approved drugs in the space – exclusivity for 12 Years
Awarded Breakthrough Therapy Designation (FDA) and SPA
Position:
Newly created position that reports to and will be a true business partner to the CEO
Highly Strategic role responsible for maximizing company value, commercialization strategy, M&A, business strategy & planning, audit oversight, investor relations, and treasury
Requirements:
Our client is looking for the best and brightest biotech CFO available – a strong key player with exceptional credentials and stellar background who is at the top of their game and at the height of their career
Proven track record within the biotech industry of generating above average shareholder returns
Public company CFO experience in Biotech or Pharma, Top tier MBA or CPA strongly preferred
Public company exit a plus
Referral Bonus*
If you or someone you know has an interest in learning more please contact our offices immediately. If you refer someone we place in the role we are offering a $2,500 Referral Bonus.
